Mediwound announces appointment of shmulik hess, ph.d. as chief operating officer and chief commercial officer

Yavne, israel, nov. 21, 2023 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced the appointment of shmulik hess, ph.d. to the positions of chief operating officer and chief commercial officer effective as of december 1, 2023. dr. hess will lead and oversee all operational and commercial activities at mediwound.
MDWD Ratings Summary
MDWD Quant Ranking